Objectives
The Imaging Unit offers cutting-edge imaging technology for in-depth exploration of animal and tissue models, emphasizing molecular imaging to support the development of drugs and tracers.
Areas of impact and applications in the field
Focusing on molecular imaging for drug and tracer development using micro-PET/CT is beneficial for the non-invasive investigation of animal models for the following reasons:
Information is obtained in the context of the entire organism and is digitized, allowing for better analysis and quantification (e.g., compared to histology).
Longitudinal studies can be carried out.
As PET/CT imaging is already employed in clinical and research studies in humans, existing preclinical techniques can be easily translated to the clinical arena.
Reverse translation from clinical to preclinical levels is also possible by simulating clinical cases in animal models and thereby improving clinical diagnosis, as well as researching the molecular processes involved in disease progression.
In this specific context, the Imaging Unit enhances AnkaTheraHub’s theranostic capabilities. It supports the demands of a diverse spectrum of investigators, particularly those who desire to use cutting-edge in-vivo imaging to progress their research.
Services
- Irradiation of small animals
- PET-CT scanning of small animals
- In vivo imaging of small animals
